drug · small molecule
patient view →LENALIDOMIDE
Marketedupdated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 66 investigational indications.
targets
CRL4(CRBN) E3 ubiquitin ligase
all catalysts(2)
approval · 2
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that